PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2924

  1. 11,226 Posts.
    lightbulb Created with Sketch. 704
    Extremely unlikely iPPS does anything useful for OA sufferers IMO. I bet it doesn't help anybody and does nothing much, or has worse side effects than the treatment.
    Can't go against the professional opinions of those who looked into this and decided not to partner on this "amazing" opportunity. The disparity between the propaganda and the result of partnering was striking!
    You're just roping the suckers in IMO.

    I reckon we'll soon be seeing delays as docs will stop sending their patients if none of the first bunch have any success.

    Hopefully this bounces after tax loss selling season and retail holders can bail and leave them all to Bell and Coppo! If it spikes I'll very happily short it again any time, unless very surprising evidence arises.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.